RFAMD

I share my personal journey with thyroid surgery performed by Dr. Michael Yeh at UCLA. I break down what happened before, during, and after my surgery for a small thyroid nodule that was diagnosed as papillary thyroid cancer.    Learn about the devastating complications I experienced, including vocal cord damage requiring an implant and nerve damage affecting my shoulder.   I discuss important research showing that many thyroid cancers don't require immediate surgery, including a Finnish cadaver study and Dr. Miyauchi's 30-year watch-and-wait approach in Kobe, Japan.    After my experience, I've interviewed over 100 thyroid specialists worldwide for my Dr. Thyroid podcast and discovered many alternatives to surgery.   This episode also covers UCLA's lack of response to my complications and how medical institutions protect doctors through reputation management. If you've been diagnosed with thyroid cancer or nodules, please research all your options, including active surveillance and ablation, before rushing into surgery.   Spanish captions available - subtítulos en español disponibles.   WATCH PART 2 https://youtu.be/9OGUIILLlpg   Resources and academic research are listed at the footer of the following report: https://docthyroid.com/what-happens-when-thyroid-surgery-turns-out-bad/   Doctor Thyroid Podcast: www.docthyroid.com RFAMD Podcast: www.rfamd.com Contact: [email protected] YouTube https://www.youtube.com/@DoctorThyroid

The Office vs. Hospital Debate: Where Should Thyroid Ablation Be Performed? A Growing Medical Debate Challenges Traditional Hospital Settings By Philip James As radiofrequency ablation (RFA) for thyroid nodules gains adoption in the United States, a crucial question emerges: should these procedures be performed in hospitals or office settings? The answer carries significant implications for both healthcare costs and patient care. The Cost Equation Understanding Facility Fees "What I'm interested in is the facility fees, which can substantially add to the cost of the procedure," explains Dr. Jagdish Dhingra in a recent Doctor Thyroid and RFAMD podcast interview with Philip James. These fees, typically associated with hospital settings, can significantly impact the overall cost of treatment. Core Expenses The fundamental costs remain consistent across settings. "The biggest item cost in the ablation procedure is the probe," Dr. Dhingra notes. "The probe costs are more or less consistent. They vary from country to country based on what kind of deal the companies have with the countries they're selling the product in, but within the United States, the costs are going to be more or less similar." Safety and Setting The Expertise Factor According to Dr. Dhingra, success depends more on provider expertise than location. "The number one thing patients should be concerned about is the skill of their provider in regard to ultrasound," he emphasizes. This expertise proves crucial for both safety and effectiveness. Hospital vs. Office Debate "I don't see how it is any more unsafe to do it in an office community setting," Dr. Dhingra states. "You are probably within five miles of patient's home, they can drive in there, they do the procedure, they drive back." The Patient Experience Comfort Considerations Office settings often provide a more comfortable environment for patients. As Dr. Dhingra explains, "You have a less intimidating, more welcoming environment which is more informal. It's like when patients come to have a needle biopsy in the office." Procedure Duration The procedure typically takes 60-90 minutes, comparable to hospital-based treatments. "Most patients tell me that because of the amount of local anesthesia used and the time that we take doing the procedure, most of them say that the experience was equal to, if not better than when they came for a biopsy," Dr. Dhingra reports. Anesthesia Considerations Local vs. General One significant advantage of office-based procedures is the use of local anesthesia. "The minute you bring general anesthesia into the equation, you automatically end up in the operating room," Dr. Dhingra explains. This requirement can substantially impact both cost and recovery time. Looking Forward The Evolution of Care As Philip James notes, "Thyroid ablation has been in the US for a relatively short period of time, about four years, and it's being adopted rapidly." This rapid adoption makes the question of setting increasingly important. Setting Guidelines Dr. Dhingra advocates for flexibility in procedure settings: "If you ever got to write guidelines, make sure that we have the facility where the procedure is done is not a limiting factor because that will take away from the purpose of doing the procedure." The Bottom Line The evidence suggests that office-based thyroid RFA procedures can offer significant advantages in terms of cost and patient comfort, provided they're performed by practitioners with appropriate expertise in ultrasound-guided procedures. Learn More To understand the full scope of this discussion, watch Dr. Dhingra's detailed interview on the Doctor Thyroid and RFAMD podcast with Philip James, where they explore the nuances of procedure settings and cost considerations.

Join us as Dr. Emad Kandil, a leading expert in thyroid ablation, sits down with Philip James in the heart of New Orleans. In this candid and insightful conversation, Dr. Kandil shares his journey from aspiring engineer to becoming a renowned thyroid surgeon, influenced by a life-changing event involving his younger brother. Against the backdrop of the city's iconic Café du Monde and a rigorous CrossFit session, the two explore the complexities of thyroid surgery, discussing why Dr. Kandil often advocates for ablation over traditional thyroidectomies to preserve patients' quality of life. As the conversation unfolds, viewers examine Dr. Kandil's commitment to research, patient care, and innovation. They venture from the cafe to the gym and finally to Dr. Kandil's clinic, where modern technology meets compassionate healthcare. For anyone considering thyroid surgery or seeking alternatives, this episode explores non-surgical options and the science behind thyroid ablation. Discover how one surgeon's philosophy and approach redefine patient outcomes—one thyroid at a time. About Dr. Emad Kandil Dr. Emad Kandil is a renowned expert in endocrine and oncological surgery. He is the Chief of General, Endocrine, and Oncological Surgery at Tulane University in New Orleans, Louisiana. He holds the prestigious Elias Hanna Chair in Surgery and is celebrated for his groundbreaking work in minimally invasive thyroid treatments, including thyroid ablation. Dr. Kandil has performed over 1,000 thyroid ablation procedures, establishing himself as a leading figure in using this innovative treatment approach in the United States. www.emadkandil.com About Philip James Philip James hosts the Doctor Thyroid podcast, a platform that provides patients with information on alternative thyroid treatments. His work focuses specifically on minimally invasive procedures like thyroid ablation. He aims to help patients avoid unnecessary thyroid surgeries, a mission close to him after his own experience with an unneeded surgery. www.docthyroid.com

In this interview with Dr. Emad Kandil, a leading expert in thyroid ablation, patient Elizabeth shares her journey of receiving conflicting medical advice regarding her thyroid nodule. After consultations with multiple doctors in New York who recommended surgery, Elizabeth sought an alternative in New Orleans with Dr. Kandil, who offered a less invasive option—thyroid ablation. This video explores the benefits of microwave ablation (MWA) as an effective treatment for thyroid nodules, avoiding the complications of surgery and long-term medication dependency. Dr. Kandil provides in-depth insights into the procedure, its success rates, and how it preserves thyroid function, challenging the traditional approach of immediate surgical intervention. For those with suspicious thyroid nodules, this discussion highlights the importance of seeking second opinions and understanding all available treatment options before making a decision. About Baird Medical Baird Medical LLC, established in 2012 and headquartered in Guangzhou, China, is a leading developer and provider of minimally invasive medical devices specializing in microwave ablation (MWA) technology. In the U.S., the company continues to expand its reach, recently receiving FDA clearance to market its microwave ablation devices for thyroid treatment. @BairdMedical www.bairdmed.com NASDAQ: BDMD Baird Medical's Assistance Center 888-508-6228 or [email protected] About Dr. Emad Kandil Dr. Emad Kandil is a renowned expert in endocrine and oncological surgery. He is the Chief of General, Endocrine, and Oncological Surgery at Tulane University in New Orleans, Louisiana. He holds the prestigious Elias Hanna Chair in Surgery and is celebrated for his groundbreaking work in minimally invasive thyroid treatments, including thyroid ablation. Dr. Kandil has performed over 1,000 thyroid ablation procedures, establishing himself as a leading figure in using this innovative treatment approach in the United States. www.emadkandil.com About Philip James Philip James hosts the Doctor Thyroid podcast, a platform that provides patients with information on alternative thyroid treatments. His work focuses specifically on minimally invasive procedures like thyroid ablation. He aims to help patients avoid unnecessary thyroid surgeries, a mission close to him after his own experience with an unneeded surgery. www.docthyroid.com

In this in-depth interview, Dr. Emad Kandil, a leading expert in thyroid ablation at Tulane University, discusses the advanced technique of Microwave Ablation (MWA) for treating thyroid nodules. Dr. Kandil explains the science behind MWA, how it compares to Radiofrequency Ablation (RFA), and addresses common misconceptions such as concerns over excessive heat. He also explores the benefits of MWA over traditional thyroid surgery, including the preservation of thyroid function and the minimization of complications. This discussion is precious for medical professionals, researchers, and individuals interested in innovative, minimally invasive treatments for thyroid conditions. Dr. Kandil emphasizes the importance of practitioner expertise in ensuring successful outcomes and offers insight into the decision-making process for selecting the most appropriate treatment method. This video offers expert-level insights if you're seeking an advanced, technical understanding of the latest thyroid ablation technologies and treatment options. About Baird Medical Baird Medical LLC, established in 2012 and headquartered in Guangzhou, China, is a leading developer and provider of minimally invasive medical devices specializing in microwave ablation (MWA) technology. In the U.S., the company continues to expand its reach, recently receiving FDA clearance to market its microwave ablation devices for thyroid treatment. @BairdMedical www.bairdmed.com NASDAQ: BDMD Baird Medical's Assistance Center 888-508-6228 or [email protected] About Dr. Emad Kandil Dr. Emad Kandil is a renowned expert in endocrine and oncological surgery. He is the Chief of General, Endocrine, and Oncological Surgery at Tulane University in New Orleans, Louisiana. He holds the prestigious Elias Hanna Chair in Surgery and is celebrated for his groundbreaking work in minimally invasive thyroid treatments, including thyroid ablation. Dr. Kandil has performed over 1,000 thyroid ablation procedures, establishing himself as a leading figure in using this innovative treatment approach in the United States. ‪@EmadKandilMD-z3d‬ www.emadkandil.com About Philip James Philip James hosts the Doctor Thyroid podcast, a platform that provides patients with information on alternative thyroid treatments. His work focuses specifically on minimally invasive procedures like thyroid ablation. He aims to help patients avoid unnecessary thyroid surgeries, a mission close to him after his own experience with an unneeded surgery. @DoctorThyroid  www.docthyroid.com

In this expert-level analysis, we compare the clinical effectiveness of Microwave Ablation (MWA) and Radiofrequency Ablation (RFA) for the treatment of thyroid nodules, with a focus on key decision-making criteria for selecting the optimal minimally invasive treatment. This detailed case study, featuring Dr. Emad Kandil and patient testimony, offers a comprehensive exploration of advanced thyroid nodule management techniques. We begin with the patient's journey, documenting her initial treatments with RFA, which resulted in limited success and the eventual regrowth of the thyroid nodule. Dr. Kandil then introduced MWA, leading to a remarkable 80% volume reduction in just three months. This transition illustrates the pivotal differences between RFA and MWA, such as the heat sink effect, and why MWA provides more precise and effective energy delivery, particularly for nodules with significant vascularization. Dr. Kandil, having performed over 1,200 thyroid ablation procedures. Key Moments: 00:10 — Explanation of the heat sink effect with MWA leading to 80% shrinkage 01:05 — Failure of RFA to induce significant nodule shrinkage 01:30 — Patient discusses the lack of pain during MWA 01:45 — Paradigm shift in the medical community regarding new ablation technologies 02:20 — Philip James introduces MWA's success where RFA failed 03:14 — The first surgeon recommended surgery, which was ultimately unnecessary 04:00 — Discovery of the thyroid nodule during a routine health check 04:55 — The emotional impact of discovering a thyroid nodule 06:10 — The patient's positive experience with Dr. Kandil 06:45 — Is it cancer? Genetic markers and biopsy results 07:50 — Dr. Kandil explains biopsy issues, suspicious cells, and genetic markers 09:00 — One surgery versus multiple surgeries: using the best available information to decide 09:40 — The large, vascular nodule and implications for treatment 10:00 — Measuring tumor volume: a shift from centimeters to milliliters (100 ml) 10:30 — The importance of seeking a second opinion 10:50 — RFA failed to provide a satisfactory response 11:10 — Detailed comparison of MWA vs. RFA, including technical and clinical differences 12:00 — Heat sink effect with RFA vs. sustained energy delivery with MWA 12:20 — MWA's ultimate success in reducing nodule size 12:50 — Dr. Kandil's experience of performing over 5,000 thyroid surgeries 13:00 — Emphasizing quality of life and preserving the thyroid, as explained by Dr. Kandil 14:30 — The importance of having MWA as a treatment option 15:50 — Treating out-of-state patients and the widespread demand for ablation technologies 16:15 — The patient reacts to the decision to avoid surgery 16:50 — Failure of RFA highlighted again, reinforcing the shift to MWA 17:50 — Not every surgeon is equal: the importance of experience and options 18:30 — Discussing the "toolbox" of available treatments offered by different healthcare providers 19:30 — The sterile hospital experience vs. the warmer, more personalized care at Dr. Kandil's office 19:54 — Dr. Kandil's bedside manner: kindness, patience, and detailed explanations 20:40 — Encouragement for patients to explore all available options; the medical community's resistance to adopting new technologies like ablation 21:30 — Dr. Kandil's experience with over 1,200 cases of thyroid ablation, establishing him as one of America's top doctors in the field About Baird Medical Baird Medical LLC, established in 2012 and headquartered in Guangzhou, China, is a leading developer and provider of minimally invasive medical devices specializing in microwave ablation (MWA) technology. In the U.S., the company continues to expand its reach, recently receiving FDA clearance to market its microwave ablation devices for thyroid treatment. @BairdMedical www.bairdmed.com About Dr. Emad Kandil Dr. Emad Kandil is a renowned expert in endocrine and oncological surgery. He is the Chief of General, Endocrine, and Oncological Surgery at Tulane University in New Orleans, Louisiana. He holds the prestigious Elias Hanna Chair in Surgery and is celebrated for his groundbreaking work in minimally invasive thyroid treatments, including thyroid ablation. Dr. Kandil has performed over 1,000 thyroid ablation procedures, establishing himself as a leading figure in using this innovative treatment approach in the United States. ‪@EmadKandilMD-z3d‬ www.emadkandil.com About Philip James Philip James hosts the Doctor Thyroid podcast, a platform that provides patients with information on alternative thyroid treatments. His work focuses specifically on minimally invasive procedures like thyroid ablation. He aims to help patients avoid unnecessary thyroid surgeries, a mission close to him after his own experience with an unneeded surgery. @DoctorThyroid www.docthyroid.com

Dr. Emad Kandil, one of the leading thyroid surgeons in the U.S. and a pioneer in non-surgical thyroid cancer treatment, is featured in this video discussing the benefits of thyroid ablation as an alternative to surgery. #thyroidnodule #thyroidcancer #thyroidsurgery  Based at Tulane University, Dr. Kandil has successfully treated numerous patients using this minimally invasive procedure, which allows for the targeted destruction of cancerous thyroid nodules without removing the thyroid gland. 00:01 - 08:03 The patient story told by Vanessa: "you have thyroid cancer" 08:04 - 12:38 Dr. Kandil discusses treating thyroid cancer without surgery In this case, Dr. Kandil treated Vanessa, who was initially diagnosed with a 1.5 cm thyroid nodule and advised by her first doctor to undergo a total thyroidectomy. Concerned about the lifelong consequences of surgery, including the need for thyroid hormone replacement, Vanessa sought out Dr. Kandil, who recommended thyroid ablation. 🛑 Three months after the procedure, her follow-up ultrasound revealed no detectable cancer, highlighting the effectiveness of ablation. The video thoroughly discusses the thyroid ablation process, including Dr. Kandil's patient-centered approach, the technical aspects of the procedure, and the post-ablation outcomes. Thyroid ablation is a promising option for patients with small, early-stage thyroid cancers who wish to avoid surgery and its associated complications. Dr. Kandil shares insights into why ablation may be a preferred treatment for preserving the thyroid while achieving cancer-free results. Key points covered: 🔹 Dr. Kandil's expertise in thyroid ablation and patient care 🔹 The non-surgical alternative for treating thyroid cancer 🔹 Patient outcomes following thyroid ablation 🔹 Comparison of thyroidectomy and ablation techniques This video is intended for viewers seeking an evidence-based understanding of thyroid ablation as a viable alternative to surgery. About Baird Medical Baird Medical LLC, established in 2012 and headquartered in Guangzhou, China, is a leading developer and provider of minimally invasive medical devices specializing in microwave ablation (MWA) technology. The company focuses on advanced treatments for thyroid nodules, offering patients a non-surgical alternative to traditional procedures. Baird Medical's MWA devices are used globally for the treatment of both benign and malignant tumors, including thyroid, liver, and lung cancers. With a solid commitment to innovation and improving patient outcomes, Baird Medical has become the first company in China to receive a Class III medical device registration certificate for MWA systems. In the U.S., the company continues to expand its reach, recently receiving FDA clearance to market its microwave ablation devices for thyroid treatment. @BairdMedical www.bairdmed.com About Dr. Emad Kandil Dr. Emad Kandil is a renowned expert in endocrine and oncological surgery. He is the Chief of General, Endocrine, and Oncological Surgery at Tulane University in New Orleans, Louisiana. He holds the prestigious Elias Hanna Chair in Surgery and is celebrated for his groundbreaking work in minimally invasive thyroid treatments, including thyroid ablation. Dr. Kandil has performed over 1,000 thyroid ablation procedures, establishing himself as a leading figure in using this innovative treatment approach in the United States. Dr. Kandil's commitment to advancing thyroid care focuses on offering patients non-surgical alternatives, such as ablation, to avoid traditional surgery. This allows for reduced recovery times and better preservation of thyroid function. His contributions to the field include over 400 research publications and numerous lectures worldwide. His research interests include endocrine tumor genetics and the development of targeted therapies for thyroid cancer. About Philip James Philip James hosts the Doctor Thyroid podcast, a platform that provides patients with information on alternative thyroid treatments. His work focuses specifically on minimally invasive procedures like thyroid ablation. He aims to help patients avoid unnecessary thyroid surgeries, a mission close to him after his own experience with an unneeded surgery. In addition to his podcast, Philip is the author of Say No to Thyroid Surgery, a book that advocates for patients to explore non-surgical options. He educates and empowers thyroid patients globally through his websites and social media, offering them access to cutting-edge treatment information and expert interviews with leading medical professionals. His passion stems from a desire to help others make informed health decisions and to provide a resource for those seeking alternatives to conventional thyroid surgery. @DoctorThyroid www.docthyroid.com  

Innovations and Issues: from the RFAMD podcast hosted by Philip James In recent years, a medical revolution has been quietly taking place in the treatment of thyroid conditions. Thyroid ablation, a procedure that offers an alternative to traditional surgery, is gaining popularity across the globe, particularly in the United States following its FDA approval. Dr. Giovanni Mauri , a leading interventional radiologist from Milan and recognized as one of the top 2% scientists by Stanford University, shares insights into the advancements and challenges of this transformative treatment. The concept of thyroid ablation isn't new; Italy saw its inception 25 years ago with experimental treatments beginning in the year 2000. However, the last three years have marked a significant turn with rapid expansion and adoption of the technique worldwide. According to Dr. Mauri, this surge is largely thanks to procedural innovations and international collaborations, notably from South Korea, where specialized devices have propelled the practice forward. Thyroid ablation works by using heat (or other methods) to destroy thyroid tissue, thus alleviating various thyroid-related conditions without the need for invasive surgery. This method preserves thyroid function and enhances patients' quality of life, a point Dr. Mauri emphasizes with great passion. The procedure is particularly appealing because it offers a quick recovery and significant reduction in health risks compared to traditional surgeries. The technique's adoption has seen a parallel rise in educational initiatives, with training programs proliferating globally to ensure that practitioners can safely and effectively perform ablations. Dr. Mauri himself is involved in such programs, including the MIT group and the Savior Thyroid School, highlighting the importance of proper training and the use of high-quality simulation tools. However, this rapid expansion is not without its problems. Dr. Mauri voices concerns about the steep learning curve associated with the procedure. He notes that many practitioners eager to incorporate thyroid ablation into their practice might not fully appreciate the complexities involved, particularly the critical role of ultrasound in guiding the ablation process. This can lead to suboptimal outcomes, making thorough training and patient selection paramount. Moreover, the innovation in thyroid ablation tools has broadened, spanning from radiofrequency devices to newer, potentially more effective technologies like microwave ablation and non-thermal methods, which promise to treat without thermal damage. Such advancements underscore a dynamic field set on improving and refining therapeutic options for patients with thyroid conditions. Yet, the allure of new technology also brings challenges. The push for rapid adoption can overshadow the necessity for comprehensive training and understanding of the intricacies involved. Stories of complications and inadequate patient selection serve as cautionary tales highlighting the need for regulatory frameworks and better educational resources for healthcare providers. As thyroid ablation continues to grow, so does the dialogue around its practice. Dr. Mauri calls for more open discussions to explore the limits and possibilities of this technique, ensuring that it remains a safe and beneficial treatment option. Through these conversations, the medical community hopes to navigate the complexities of innovation while maintaining the highest standards of patient care. While thyroid ablation stands as a beacon of progress in medical treatments for thyroid conditions, it requires a balanced approach of innovation, education, and ethical practice. As we look to the future, the contributions of pioneers like Dr. Mauri and ongoing global collaboration will be crucial in shaping the path forward for this promising medical advancement.   FIND MORE INFO ABOUT THYROID ABLATION, CLICK HERE    

In a world where misinformation can spread as rapidly as legitimate data, discerning the truth becomes a critical skill—especially when it comes to our health. Dr. John Whyte, Chief Medical Officer at WebMD, shares his insights on how patients can navigate the sea of health information online to find trustworthy resources and take control of their personal health. The Power of Information Dr. Whyte begins by emphasizing the importance of quality information, which he argues is more accessible than ever thanks to digital advancements. "Better information leads to better health," he says, echoing WebMD's philosophy. In the era of the internet, the adage "knowledge is power" holds particularly true in the realm of healthcare. Quality information equips patients with the power to make informed decisions about their health, turning them into advocates for their own care. Sorting Fact from Fiction The challenge for many, Dr. Whyte notes, is the overwhelming amount of information available—an issue compounded by the rapid pace at which medical knowledge evolves. "Medical knowledge doubles about every 73 days," he states, highlighting the difficulty for even the most diligent professionals to stay current. In this environment, patients must become their own advocates and learn to differentiate between reliable information and misleading data. Whyte is concerned about the rise of misinformation, which can equate unverified opinions with scientific evidence. He stresses the importance of scrutinizing health information with the same rigor one might apply to financial decisions. This means considering the source's credibility, transparency, and the replicability of the data. Reliable sites like WebMD help users navigate this by providing clearly dated and expert-reviewed content. The Role of Technology in Personal Health Dr. Whyte is a strong proponent of using technology to enhance personal health management. From wearables that track physical activity to apps that monitor sleep and dietary habits, digital tools offer a wealth of personalized data that can lead to healthier lifestyle choices. He shares his personal experiences with biohacking gadgets like Lumen, a device that measures metabolic fuel use, to illustrate how specific tools can help tailor health strategies to individual needs. DIY Health: A Blessing and a Curse The abundance of health-related information and tools can empower patients but also overwhelm them. Dr. Whyte calls this the "DIY approach" to health, where individuals take on the role of managing their own care without sufficient medical guidance. While he champions the use of technology, he cautions against its pitfalls, particularly when individuals rely too heavily on unvalidated sources or misinterpret the data. The Future of Health Information Looking ahead, Dr. Whyte is optimistic about the potential of AI and machine learning to transform healthcare. He envisions a future where AI can provide empathetic, accurate support that complements traditional healthcare services. However, he acknowledges that the technology is not yet perfect and emphasizes the importance of continuing to refine these tools to avoid the spread of "hallucinated" misinformation. Empowering Patients Through Trustworthy Resources In conclusion, Dr. John Whyte advocates for a balanced approach to digital health information. By critically evaluating sources, utilizing technological tools judiciously, and always seeking professional advice when necessary, patients can take charge of their health confidently and safely. In an age where information is both a resource and a hazard, being a discerning consumer is perhaps the most important skill of all. Dr. John Whyte is the Chief Medical Officer at WebMD, where he leverages his extensive background in both medicine and public health policy to enhance healthcare information accessibility and accuracy for the public. A passionate advocate for consumer-centered healthcare, Dr. Whyte is dedicated to empowering individuals with reliable and actionable health data. With a medical degree from the University of Pennsylvania School of Medicine and a master's degree in public health from Harvard, he has served in leadership roles at the Food and Drug Administration and Discovery Channel Global Education Partnership, among others. Dr. Whyte is a prolific author and speaker, focused on improving patient education and health outcomes through innovation in digital health and media. About Philip James As the host of the popular RFAMD and Doctor Thyroid podcasts, Philip James remains committed to sharing inspiring stories, valuable insights, and groundbreaking discoveries in the world of healthcare, making a positive impact on the lives of countless listeners. Philip's thought-provoking interviews have covered a wide range of healthcare topics, from cutting-edge technologies and surgical advancements to patient experiences and the impact of medical research on society. About RFAMD RFAMD is solely dedicated to helping healthcare organizations build deeper, enduring relationships with patients. Our team brings together expertise and insights to create enterprise-wide solutions that transform the patient experience. With years of experience in understanding the patient's journey, we can help healthcare organizations thrive in today's patient-centered healthcare market. Our range of solutions includes smart, measurable patient acquisition programs, physician marketing touch-points that drive referrals into priority service lines, and credible, easy-to-digest content at the point of care and beyond, in patients' preferred formats and languages. We also provide brand strategies that increase patient preference and physician referrals and differentiate your brand in the market through reputation-building tools. Our commitment is to enable providers and payers to deliver personalized care by activating, educating, and motivating patients to prioritize their health every day. As your strategic partner, we combine our unique capabilities and industry expertise to better engage patients at every step of their health journey. Our goal is to help healthcare organizations achieve stronger patient and member outcomes, sustained improvements in brand reputation, measurable gains in market share, and increased revenue. www.rfamd.com    

Durante una entrevista detallada en el podcast RFAMD, el anfitrión Philip James conversó con la Dra. Ana Voogd, una distinguida cirujana de cabeza y cuello con más de 30 años de experiencia, sobre la integración gradual de la terapia de ablación tiroidea en el panorama médico de Argentina. La Dra. Voogd, que dirige el departamento de cirugía de cabeza y cuello en uno de los hospitales más grandes de Argentina, proporcionó perspectivas valiosas sobre el enfoque evolutivo del país hacia el cuidado del tiroides. Un Paso Hacia Procedimientos Menos Invasivos La Dra. Voogd explicó la ablación tiroidea en términos sencillos, destacando su carácter no quirúrgico y percutáneo, que utiliza agujas para crear necrosis dentro de los nódulos tiroideos. Este proceso detiene efectivamente el crecimiento del nódulo y mejora los síntomas sin necesidad de cirugía, marcando un avance significativo en la mejora de la calidad de vida del paciente y en la preservación de la glándula tiroidea. A la Par con los Estándares Internacionales La adopción de técnicas de ablación tiroidea en Argentina, que han sido utilizadas durante décadas en países como Corea del Sur e Italia, es relativamente reciente. La Dra. Voogd señaló la llegada de equipos especializados para la ablación por radiofrecuencia hace dos o tres años como un punto de inflexión, lo que permitió a los proveedores de atención médica locales ofrecer este tratamiento. Aunque Argentina está poniéndose al día, la introducción de esta tecnología ha sido recibida con entusiasmo tanto por los profesionales médicos como por los pacientes, ofreciendo una opción no quirúrgica para tratar los nódulos tiroideos y, en algunos casos, el cáncer de tiroides. Desafíos de Acceso y Asequibilidad La conversación con la Dra. Voogd también abordó los desafíos de acceder a la ablación tiroidea en Argentina, donde la disponibilidad del procedimiento varía significativamente entre los sectores de salud pública y privada. En el sector público, la ablación tiroidea no es ampliamente aceptada, mientras que el sector privado ofrece más flexibilidad pero con costos variables. La Dra. Voogd señaló que, aunque el costo del procedimiento está influenciado por el precio de consumibles como las agujas, sigue siendo comparable a los precios internacionales, haciéndolo accesible para aquellos con seguro adecuado o los medios financieros para la atención privada. Resultados Alentadores y Alta Satisfacción del Paciente La Dra. Voogd compartió sus experiencias positivas con la ablación tiroidea, mencionando el tratamiento de más de 100 nódulos con reducciones notables en tamaño y alivio de síntomas. Estos resultados sugieren que la ablación tiroidea podría cambiar significativamente el paisaje del tratamiento tiroideo en Argentina, ofreciendo una alternativa efectiva a la cirugía convencional. Una Perspectiva Más Amplia y Perspectivas Futuras Al concluir la entrevista, la Dra. Voogd enfatizó la importancia de crear conciencia sobre la ablación tiroidea entre los pacientes con nódulos tiroideos. Animó a los pacientes a considerar esta opción de tratamiento innovadora, que permite un rápido retorno a las actividades diarias, sin cicatrices visibles y con mínimas molestias post-procedimiento. Destacó un caso particularmente memorable de un paciente que experimentó una mejora significativa después de años de sufrimiento, ilustrando el profundo impacto de la ablación tiroidea en la vida de los individuos. En resumen, las perspectivas compartidas por la Dra. Ana Voogd en el podcast RFAMD iluminan el abrazo gradual de Argentina hacia la ablación tiroidea como opción de tratamiento. Este cambio hacia métodos menos invasivos representa un desarrollo significativo en el sistema de atención médica del país, ofreciendo resultados de tratamiento mejorados y mejorando la calidad de vida para los pacientes con condiciones tiroideas. FIND MORE INFO ABOUT THYROID ABLATION, CLICK HERE   🔷🔷🔷🔷 About Philip James As the host of the popular RFAMD and Doctor Thyroid podcasts, Philip James remains committed to sharing inspiring stories, valuable insights, and groundbreaking discoveries in the world of healthcare, making a positive impact on the lives of countless listeners. Philip's thought-provoking interviews have covered a wide range of healthcare topics, from cutting-edge technologies and surgical advancements to patient experiences and the impact of medical research on society. LinkedIn About RFAMD RFAMD is solely dedicated to helping healthcare organizations build deeper, enduring relationships with patients. Our team brings together expertise and insights to create enterprise-wide solutions that transform the patient experience. With years of experience in understanding the patient's journey, we can help healthcare organizations thrive in today's patient-centered healthcare market. Our range of solutions includes smart, measurable patient acquisition programs, physician marketing touch-points that drive referrals into priority service lines, and credible, easy-to-digest content at the point of care and beyond, in patients' preferred formats and languages. We also provide brand strategies that increase patient preference and physician referrals and differentiate your brand in the market through reputation-building tools. Our commitment is to enable providers and payers to deliver personalized care by activating, educating, and motivating patients to prioritize their health every day. As your strategic partner, we combine our unique capabilities and industry expertise to better engage patients at every step of their health journey. Our goal is to help healthcare organizations achieve stronger patient and member outcomes, sustained improvements in brand reputation, measurable gains in market share, and increased revenue. www.rfamd.com